Maven Health

To maintain affordable and high-quality healthcare services a pivot is needed from traditional curative health care to preventive health care. Primary care health professionals are eager to use new methods to accommodate this shift but lack the technology, scale, and data science to move forward. Current standard blood tests are invasive, infrequent, and often over- or underestimate the risk for metabolic diseases. To achieve effective preventive health care, personalized tests are essential. Maven Health generates an accurate picture of personal metabolic health through our proprietary data platform which combines machine learning algorithms, data infrastructure and metabolomics. The goal is to empower primary healthcare providers to identify people at risk of metabolic diseases but who would otherwise be missed by the traditional healthcare system. Maven Health closely collaborates with primary care providers to finetune the specific targets and outcomes of their testing, making their outputs directly applicable to the current healthcare system. The health analyses are generated from the metabolite profiles of saliva, which is collected non-invasively. Metabolites are measured by Nuclear Magnetic Resonance, a technology that has seen reduction in cost and increase in sensitivity in recent years. Strong growth is predicted in the Swiss preventive healthcare market, from CHF 2.9 billion in 2022 up to CHF 7.7 billion in 2028.